Facial telangiectasia
Conditions
Interventions
Intervention group:Treating with 532nm KTP laser
Control group:Treating with 595nm Pulsed dye laser
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Fitzpatrick skin type III or IV bibuccal telangiectasia patients with vascular diameter within <2mm; 2) Healthy adults aged 18-65 years (inclusive) of any gender; 3) The patient voluntarily participated in the clinical observation, signed the informed consent form, and was willing to cooperate with the follow-up observation; 4) Have good communication skills and comprehension skills.
Exclusion criteria
Exclusion criteria: 1) Those with other facial symptoms who do not meet the inclusion criteria; 2) Patients with a history of skin cancer (melanoma), etc.; 3) pregnant or lactating women; 4) Patients with photosensitive diseases such as chronic actinic dermatitis, polymorphic light eruption, and photosensitive epilepsy; 5) Have received facial laser, intense pulsed light, radiofrequency, focused ultrasound and other photoelectric therapy or botulinum toxin droplet injection treatment within one month; 6) Those who have used tretinoin (in the past 6 months); 7) Patients with other serious organic lesions or systemic diseases; 8) Patients who are unwilling to sign the informed consent form, unwilling to cooperate; 9) Those with a history of psychological and psychiatric illness, recent history of alcoholism or drug abuse; 10) Other conditions that are judged by the investigator to be unsuitable for receiving 532nm KTP laser or 595nm pulsed dye laser.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Standardized photographs;Average hemoglobin concentration; | — |
Countries
China
Contacts
Public ContactWei Zhang
Shanghai Skin Disease Hospital
Outcome results
None listed